Cancers Where Ultrasound Plays a Role: A Patient's Overview

Ultrasound is one of several imaging tools used in cancer care — it contributes to the detection, characterisation, monitoring and biopsy guidance of many cancers, including breast, thyroid, liver, kidney, ovarian and prostate. It is rarely the only test used and is almost never the sole screening tool, but its radiation-free profile, real-time imaging and accessibility give it an important place. The right combination of imaging tests for your situation is decided by your treating doctor.

This article is general background for patients trying to understand where ultrasound sits in the broader cancer-imaging picture. It is not medical advice — only your physician can decide what is appropriate for you.

Why ultrasound has a role in cancer care

The features that make ultrasound useful in oncology:

• Radiation-free — see is ultrasound safe. Useful for repeated monitoring of known lesions over months and years without cumulative radiation dose.

• Real-time imaging — allows the radiologist to assess lesion characteristics, movement, vascularity (using Doppler) and tissue stiffness (with elastography) in one sitting.

• Accessible and quick — most centres have ultrasound capability; scans take 15–30 minutes typically.

• Guides biopsies precisely — image-guided needle biopsy under ultrasound is the standard for many lesion sampling procedures.

• Distinguishes solid from fluid — a critical first question when a mass is found.

• No contrast or sedation required for routine scans.

What ultrasound is not ideal for: deep abdominal tumours hidden behind bowel gas, lung lesions (air scatters sound), bone-encased structures (skull, vertebral bodies), staging of many cancers, and most population-wide cancer screening — where CT, MRI or modality-specific programmes (mammography, low-dose CT for lung) usually do more.

Breast cancer

Breast ultrasound — see our breast cancer screening guide — complements mammography, particularly for women with dense breasts and for evaluating a specific lump at any age. It distinguishes solid masses from cysts, characterises the features of solid lesions, and guides core-needle biopsy. MRI is added for high-risk screening. The right combination is decided by your physician.

Thyroid nodules and thyroid cancer

Thyroid nodules are common — perhaps 50% of adults have one detectable on ultrasound by age 60. The vast majority are benign. Ultrasound is the primary imaging tool for the thyroid because:

• It clearly characterises nodule features (size, composition, margins, calcifications, vascularity)

• It applies the TI-RADS (Thyroid Imaging Reporting and Data System) classification to estimate cancer risk

• It guides fine-needle aspiration biopsy (FNAB) when indicated

• It allows long-term monitoring of benign nodules without radiation

A thyroid ultrasound takes 10–15 minutes. The patient lies on their back with the neck extended; gel is applied to the front of the neck and the probe scans across the thyroid lobes and lymph node regions. No preparation is required.

Liver lesions

Abdominal ultrasound is often the first test when liver disease, abnormal liver-function tests or vague abdominal symptoms are evaluated. It can detect:

• Liver cysts (almost always benign)

• Haemangiomas (benign vascular tumours, very common)

• Focal nodular hyperplasia and adenomas

• Hepatocellular carcinoma (primary liver cancer)

• Metastatic disease from other primary cancers

For patients with cirrhosis or chronic hepatitis B/C, surveillance ultrasound at 6-monthly intervals (often combined with serum alpha-fetoprotein) is a widely recommended screening protocol for hepatocellular carcinoma. CT or MRI confirms and characterises any suspicious lesion. Contrast-enhanced ultrasound (CEUS) is an emerging technique that adds vascular information.

Kidney masses

Kidney lesions are frequently found incidentally during abdominal ultrasound for unrelated reasons. Ultrasound classifies most of them into:

• Simple cysts (very common, almost always benign — the Bosniak classification)

• Complex cysts (requiring follow-up or further imaging)

• Solid masses (further evaluation with CT or MRI)

For known small solid kidney masses being monitored ("active surveillance"), ultrasound is a reasonable follow-up modality between CT scans to reduce cumulative radiation.

Ovarian and gynecological cancers

Pelvic ultrasound — abdominal and/or transvaginal — is the standard initial imaging for pelvic symptoms in women. It evaluates:

• Ovarian cysts (extremely common; vast majority benign)

• Ovarian masses (the IOTA classification helps estimate cancer risk)

• Endometrial thickening (which may need biopsy)

• Uterine fibroids and other benign conditions

Transvaginal ultrasound — see is ultrasound gel safe for intimate use — gives the clearest pelvic-organ images. For suspected ovarian cancer, ultrasound features plus blood tests (CA-125) typically lead to MRI for further characterisation and surgical planning.

Prostate

Transrectal ultrasound (TRUS) is the standard imaging method for the prostate. It is most commonly used to guide biopsy when prostate cancer is suspected (typically based on PSA results and digital rectal exam). Increasingly, MRI of the prostate is performed first to identify suspicious areas, and TRUS-MRI fusion biopsy targets those areas precisely. TRUS alone is not a primary screening modality for prostate cancer.

Abdominal lymph nodes and other findings

Abdominal ultrasound can detect enlarged lymph nodes, fluid in the abdomen (ascites), masses near major vessels, and gallbladder or pancreas lesions. For pancreas lesions, endoscopic ultrasound (EUS) — performed through the upper digestive tract during endoscopy — gives much better images than surface ultrasound and is used in pancreatic cancer evaluation.

Biopsy guidance

For many superficial and mid-depth lesions, ultrasound-guided needle biopsy is the standard sampling method because:

• Real-time visualisation of the needle entering the lesion

• No radiation

• Minimal patient preparation

• Fast and well-tolerated

Common ultrasound-guided biopsies: breast core biopsy, thyroid FNAB, liver core biopsy, kidney biopsy, lymph-node biopsy. Pathology results from these samples drive treatment decisions.

Cancer monitoring (surveillance)

For patients with known cancers being treated or monitored, ultrasound is sometimes used for follow-up because it avoids cumulative radiation. Examples: liver metastasis surveillance, thyroid post-thyroidectomy neck surveillance, scrotal/testicular monitoring. The choice depends on what the oncologist needs to see and how often.

What ultrasound generally does not do well in oncology

To set realistic expectations:

• Whole-body cancer screening — no single ultrasound exam screens the whole body. Screening is organ- and risk-specific.

• Lung cancer screening — air-filled lung tissue scatters sound; low-dose CT is the established lung-cancer screening modality for high-risk smokers.

• Brain tumours — bone blocks ultrasound; MRI is the imaging of choice.

• Most bone tumours — CT and MRI dominate.

• Comprehensive staging of most established cancers — CT and/or MRI typically provide the staging picture.

Ultrasound is a complement, not a substitute.

What to ask your doctor

• For my specific risk profile, what cancer screening tests are recommended?

• If ultrasound finds something, what is the typical next step?

• For follow-up of a known benign finding, can ultrasound replace CT to reduce radiation?

• Is image-guided biopsy under ultrasound feasible for my finding?

• Are there established surveillance protocols I should be on (liver in chronic hepatitis B, breast in dense breasts, thyroid nodule follow-up, etc.)?

A printed record of imaging reports kept over the years helps both you and your doctor track changes confidently.

A practical note on awareness

Most cancers are found earlier when patients pay attention to changes — new lumps, persistent pain, unexplained weight loss, persistent fatigue, changes in bowel or bladder habits, persistent cough, a sore that doesn't heal, abnormal bleeding — and seek timely evaluation. Ultrasound is one of many tools the doctor may use to evaluate what is found. Population-level cancer screening protocols (cervical screening, mammography, colonoscopy for colon cancer, low-dose CT for high-risk lung cancer) operate separately from ultrasound.

Pioma Chemtech is a specialty chemical manufacturer based in India and not a clinical authority. The information here is general and educational. Your treating doctor is the right person to discuss your specific situation, family history and the appropriate combination of tests.

Frequently Asked Questions

Can ultrasound screen for cancer across the whole body?

No. Ultrasound is organ-specific. There is no single ultrasound exam that screens the whole body for cancer. Screening protocols are designed cancer-by-cancer with appropriate modalities — mammography for breast, low-dose CT for lung in high-risk smokers, colonoscopy for colon, Pap test plus HPV testing for cervix, and so on.

Is ultrasound good for detecting early-stage cancers?

It depends on the cancer. Ultrasound is excellent for detecting small thyroid nodules, characterising small breast lesions, finding small ovarian cysts and identifying focal liver lesions. It is less useful for early-stage cancers in lung, brain, bone or deep retroperitoneal locations.

Why isn't ultrasound used as a routine screening test for healthy people?

Because most cancers in the general population are uncommon, and broad ultrasound screening tends to find many benign findings that lead to anxiety and unnecessary further tests without proportional life-saving benefit. Screening programmes are designed for specific cancers where evidence shows screening improves outcomes — and ultrasound's role within them is targeted (e.g. dense-breast supplement to mammography).

Can ultrasound miss a cancer that's there?

Yes, occasionally — like any imaging test, ultrasound has sensitivity and specificity limits. False negatives can occur, especially for deep, small or anatomically hidden lesions, or in patients whose body habitus makes scanning difficult. This is one reason multiple modalities and follow-up are part of cancer care.

Is ultrasound used during cancer treatment?

Yes — to monitor known lesions, to guide biopsies for tissue diagnosis, to assess treatment response in certain settings, and to evaluate complications (e.g. detecting an abscess or fluid collection). It is one tool in the oncology imaging toolkit.

Does ultrasound expose me to radiation?

No — ultrasound uses sound waves, not ionising radiation. See is ultrasound safe.

Should I ask for an ultrasound if I am worried about cancer?

The right question is to share your specific concerns with your doctor — family history, symptoms, age, lifestyle factors — and ask them what imaging or screening fits your situation. They will choose ultrasound, mammography, CT, MRI, endoscopy, blood tests or other tools in the combination that addresses your individual risk profile.

Ultrasound is a valuable, accessible, radiation-free tool in cancer care — used in coordination with other imaging and laboratory tests, decided by your treating physician. Awareness of symptoms, established screening protocols and a steady relationship with a doctor remain the foundations.

— Pioma Chemtech, a specialty chemical manufacturer based in India, is available for bulk and commercial supply of medical-grade ultrasound and ECG gel.